Showing 8,661 - 8,680 results of 60,198 for search '(( 5 we decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 8661

    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  2. 8662

    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  3. 8663

    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  4. 8664

    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  5. 8665

    Image_3_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  6. 8666

    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  7. 8667

    Image_2_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  8. 8668

    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  9. 8669

    Image_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.tif by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  10. 8670
  11. 8671
  12. 8672

    Cohort characteristics. by Vincent Pey (21433304)

    Published 2025
    “…</p><p>Results</p><p>Upon initiation of CPB we observed a significant decrease in arterial whole blood redox potential (101.90 mV + /- 11.52 vs. 41.80 mV + /- 10,26; p < 0.0001). …”
  13. 8673

    DataSheet_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.docx by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  14. 8674

    DataSheet_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.docx by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  15. 8675

    DataSheet_1_USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway.docx by Sudong Xue (8815673)

    Published 2020
    “…In this study, we examined the expression and prognostic significance of USP5 in NSCLC. …”
  16. 8676

    Video_7_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

    Published 2020
    “…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT<sub>2</sub> (Cyproheptadine; Cypr), 5-HT<sub>2A</sub> neutral antagonist (Volinanserin; Volin), 5-HT<sub>2C</sub> neutral antagonist (SB 242084), and 5-HT<sub>2B/2C</sub> inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”
  17. 8677

    Image_3_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

    Published 2020
    “…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT<sub>2</sub> (Cyproheptadine; Cypr), 5-HT<sub>2A</sub> neutral antagonist (Volinanserin; Volin), 5-HT<sub>2C</sub> neutral antagonist (SB 242084), and 5-HT<sub>2B/2C</sub> inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”
  18. 8678

    Image_2_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

    Published 2020
    “…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT<sub>2</sub> (Cyproheptadine; Cypr), 5-HT<sub>2A</sub> neutral antagonist (Volinanserin; Volin), 5-HT<sub>2C</sub> neutral antagonist (SB 242084), and 5-HT<sub>2B/2C</sub> inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”
  19. 8679

    Image_4_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.JPEG by Henryk Majczyński (830716)

    Published 2020
    “…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT<sub>2</sub> (Cyproheptadine; Cypr), 5-HT<sub>2A</sub> neutral antagonist (Volinanserin; Volin), 5-HT<sub>2C</sub> neutral antagonist (SB 242084), and 5-HT<sub>2B/2C</sub> inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”
  20. 8680

    Video_3_Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats.WMV by Henryk Majczyński (830716)

    Published 2020
    “…Little is known about the role of 5-HT receptors in the control of voluntary locomotion, so we administered inverse agonists of 5-HT<sub>2</sub> (Cyproheptadine; Cypr), 5-HT<sub>2A</sub> neutral antagonist (Volinanserin; Volin), 5-HT<sub>2C</sub> neutral antagonist (SB 242084), and 5-HT<sub>2B/2C</sub> inverse agonist (SB 206553) receptors intrathecally in intact rats and monitored their effects on unrestrained locomotion. …”